STATs: Transcriptional control and biological impact

Nature Reviews Molecular Cell Biology

Volumn 3, Issue 9, 2002, Pages 651-662

  Levy, David E ^a   Darnell, J E ^b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; CELL SURFACE RECEPTOR; STAT PROTEIN; STAT1 PROTEIN; STAT2 PROTEIN; STAT3 PROTEIN; STAT4 PROTEIN; STAT5 PROTEIN; STAT6 PROTEIN; TRANSCRIPTION FACTOR;

CELL GROWTH; GENE ACTIVATION; GENE EXPRESSION; HOMEOSTASIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TRANSPORT; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

ANIMALS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMANS; JANUS KINASE 1; MODELS, MOLECULAR; PHOSPHORYLATION; PROTEIN CONFORMATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN TRANSPORT; PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC;

EID: 0036731485     PISSN: 14710072     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrm909     Document Type: Review

References (161)

1. The proteins of ISGF·3: The interferon α-induced transcriptional activator, define a gene family involved in signal transduction
2. Proteins of transcription factor ISGF-3: One gene encodes the 91 and 84 kDa ISGF-3 proteins that are activated by inteferon-α
3. Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor
4. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins
5. How cells respond to interferons
6. Jaks, STATs, cytokine signal transduction, and immunoregulation: Are we there yet?
7. STAT proteins and transcnptional responses to extracellular signals
8. DNA binding of in vitro activated Stat1 α, Stat1 β, and truncated Stat1: Interaction between NH2 terminal domains stabilizes binding of two dimers to tandem DNA sites
9. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway
10. Stat recruitment by tyrosine-phosphorylated cytokine receptors: An ordered reversible affinity-driven process
11. JAKs, STATs and Src kinases in hematopoiesis
12. An amino acid substitution in the Drosophila hopTum-I Jak kinase causes leukemia-like defects
13. The roles of the Drosophila JAK/STAT pathway
14. Ligand-independent oligomerization of cell-surface erythropoietin receptor is mediated by the transmembrane domain
15. A Stat3-interacting protein (StlP1) regulates cytokine signal transduction
16. The WD motif-containing protein receptor for activated protein kinase C (RACK1) is required for recruitment and activation of signal transducer and activator of transcription 1 through the type I interferon receptor
17. Human elongator facilitates RNA polymerase Il transcription through chromatin
18. Biomolecular interaction analysis of IFN γ-Induced signaling events in whole-cell lysates: Prevalence of latent STAT1 in high-molecular weight complexes
19. How Stat1 mediates constitutive gene expression: A complex of unphosphorylated Stat1 and IRF1 supports transcription of the LMP2 gene
20. Crystal structure of a tyrosine phosphorylated STAT-1 dimer bound to
21. Cellular physiology of STAT3: Where's the cytoplasmic monomer?
22. ISGF3γ p48, a specificity switch for IFN activated transcription factors
23. Isolation and characterization of a human STAT1 gene regulatory element. Inducibility by interferon (IFN) types I and II and role of IRF regulatory factor-1
24. Serine phosphorlation of STATs
25. Caveolins, a family of scaffolding proteins for organizing 'preassembled signaling complexes' at the plasma membrane
26. Cytokine signaling. STATs in plasma membrane rafts
27. A weak signal for strong responses: Interferon-α/β revisited
28. The ceveolin triad: Caveolae biogenesis, cholesterol trafficking, and signal transduction
29. SOCS proteins: Negative regulators of cytokine signaling
30. Inhibition of IL-2-induced Jak-STAT signaling by glucocorticolds
31. Inhibition of intedeukin 2 signaling and signal transducer and activator of transcription (STAT)5 activation during T cell receptor-mediated feedback inhibition of T cell expansion
32. Activation of protein kinase A inhibits interferon induction of the Jak/Stat pathway in U266 cells
33. STATs and gene regulation
34. Three-dimensional structure of the Stat3β homodimer bound to DNA
35. Dissociation time from DNA determines transcriptional function in a STAT1 linker mutant
36. Structure of the amino-terminal protein interaction domain of STAT-4
37. Role of the Stat4 N domain in receptor proximal tyrosine phosphorylation
38. Cooperative DNA binding and sequence selective recognition conferred by the Stat amino terminal domain
39. Functional importance of Stat3 tetramerization in activation of the α2-macroglobulin gene
40. The significance of tetramerization in promoter recruitment by Stat5
41. Amino-terminal signal transducer and activator of transcription (STAT) domains regulate nuclear translocation and STAT deactivation
42. Enhancement of antiproliferative activity of γ interferon by the specific inhibition of tyrosine dephosphorylation of Stat1
43. Nucleocytoplasmic transport: The soluble phase
44. Extracellular signal-dependent nuclear import of Stat1 is mediated by nuclear pore-targeting complex formation with NPI-1, but not Rch1
45. Regulated nuclear import of the STAT1 transcription factor by direct binding of importin-α
46. Argine/lysine-rich NLSs mediate interactions between dimeric STATs and importin α5
47. Arginine/lysine-rich structural element is involved in interferon-induced nuclear import of STATs
48. Constitutive and IFN-γ-induced nuclear import of STAT 1 proceed through independent pathways
49. Defective TNF-α-induced apoptosis in STAT1-null cells due to low constitutive levels of caspases
50. Nuclear export signal located within the DNA-binding domain of the STAT1 transcription factor
51. Nucleocytoplasmic translocation of STAT1 is regulated by leucine-rich export signal in the coiled-coil domain
52. A nuclear protein tyrosine phosphatase is required for the inactivation of Stat1
53. The T-cell protein tyrosine phosphatase
54. Identification of a nuclear Stat1 protein tyrosine phosphatase
55. A nuclear protein tyrosine phosphatase TC-PTP is a potential negative regulator of the PRL-mediated signaling pathway: Dephosphorylation and deactivation of signal transducer and activator of transcription 5a and 5b by TC-PTP in nucleus
56. The T cell protein tyrosine phosphatase is a negative regulator of Janus family kinases 1 and 3
57. A cytosolic protein-tyrosine phosphatase PTP1B specifically dephosphorylates and deactivates prolactin-activated STAT5a and STAT5b
58. Shp-2 tyrosine phosphatase functions as a negative regulator of the interferon-stimulated Jak/STAT pathway
59. Differential regulation of the α/β interferon-stimulated Jak/Stat pathway by the SH2 domain-containing tyrosine phosphatase SHPTP1
60. Regulation of interferon-α responsiveness by the duration of Janus kinase activity
61. Specific recruitment of SH-PTP-1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals
62. The carboxyl terminus of the granulocyte colony-stimulating factor receptor, truncated in patients with severe congenital neutropenia/acute myeloid leukemia, is required for SH2-containing phosphatase-1 suppression of Stat activation
63. PTP1B regulates leptin signal transduction in vivo
64. Negative regulation of the JAK/STAT pathway
65. A new protein containing an SH2 domain that inhibits JAK kinases
66. Structure and function of a new STAT-induced STAT inhibitor
67. A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors
68. H cell lineage commitment and maintenance
69. Polycystic kidneys and chronic inflammatory lesions are the delayed consequences of loss of the suppresor of cytokine signaling-1 (SOCS-1)
70. The SOCS box of suppressor of cytokine signaling-1 is important for inhibition of cytokine action in vivo
71. SOCS3 is essential in the regulation of fetal liver erythropoiesis
72. Placental defects and embryonic lethality in mice lacking suppressor of cytokine signaling 3
73. Socs-6 binds to insulin receptor substrate 4, and mice lacking the Socs-6 gene exhibit mild growth retardation
74. Specific inhibition of Stat3 signal transduction by PIAS3
75. Modulation of STAT signaling by STAT-interacting proteins
76. Polarity determination in the Drosophila eye: A novel role for unpaired and JAK/STAT signaling
77. A Drosophila PIAS homologue negatively regulates Stat92E
78. A new RING for SUMO wrestling transcriptional responses into nuclear bodies with PIAS family E3 SUMO ligases
79. Specific ablation of Stat3β distorts the pattern of Stat3-responsive gene expression and impairs recovery from endotoxic shock
80. Negative regulation of STAT92E by an N-terminally truncated STAT protein derived from an alternative promoter site
81. Identification of a Stat gene that functions in Drosophila development
82. Marelle acts downstream of the Drosophila HOP/JAK kinase and encodes a protein similar to the mammalian STATs
83. Spacing of palindromic half sites as a determinant of selective STAT DNA binding and transcriptional activity
84. DNA binding specificity of different STAT proteins. Comparisons of in vitro specificity with natural target sites
85. Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays
86. Arginine methylation of STAT1 modulates IFNα/β-induced transcription
87. Cooperation of the transcriptional co-activators CBP and p300 with Stat6
88. Acetylation by histone acetyltransferase CREB-binding protein/p300 of STAT6 is required for transcriptional activation of the 15-lipoxygenase-1 gene
89. STAT3 acts as a co-activator of glucocorticoid receptor signaling
90. Antiviral response in cells containing Stat1 with heterologous transactivation domains
91. Ser 727-dependent recruitment of MCM5 by Stat1α in IFN-γ-induced transcriptional activation
92. Stat protein transactivation domains recruit p300/CBP through widely divergent sequences
93. IFN-stimulated transcription through a TBP·free acetyltransferase complex escapes viral shutoff
94. Transcriptional regulation through mediator-like co-activators in yeast and metazoan cells
95. Stat 1 depends on transcriptional synergy with Sp1
96. Activation of the MHC class II transactivator CIITA by interferon-γ requires cooperative interaction between Stat1 and USF-1
97. Functional interactions between Stat5 and the glucocorticoid receptor
98. Characterization of an intedeukin 4 (IL-4) responsive region in the immunoglobulin heavy chain germline epsilon promoter: Regulation by NF-IL-4, a C/EBP family member and NF-κB/p50
99. Functional association of Nmi with Stat5 and Stat1 in IL-2- and IFNγ-mediated signaling
100. Cooperative transcriptional activity of Jun and Stat3β, a short form of Stat3
101. Synergistic signaling in fetal brain by STAT3-Smad 1 complex bridged by p300
102. Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways
103. Kinetics of a γ interferon response: Expression and assembly of CIITA promoter IV and inhibition by methylation
104. Mutations affecting segment number and polarity in Drosophila
105. Identification of the first invertebrate intedeukin JAK/STAT receptor, the Drosophila gene domeless
106. A JAK-STAT pathway regulates wing vein formation in Drosophila
107. Control of stem cell self-renewal in Drosophila spermatogenesis by JAK-STAT signaling
108. Stem cell self-renewal specified by JAK-STAT activation in response to a support cell cue
109. Paracrine signaling through the JAK/STAT pathway activates invasive behavior of ovarian epithelial cells in Drosophila
110. Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses
111. Stat5a is mandatory for adult mammary gland development and lactogenesis
112. −/− mice: A direct role for Stat5 in Bcl-X(L)induction
113. Ineffective erythropoiesis in Stat5a(-/-) 5b(-/-) mice due to decreased survival of early erythroblasts
114. Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells
115. Reduced Lymphomyeloid repopulating activity from adult bone marrow and fetal liver of mice lacking expression of STAT5
116. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality
117. Roles of STAT3 defined by tissue-specific gene targeting
118. What does Stat3 do?
119. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease
120. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway
121. Immune response in Stat2 knockout mice
122. Impairment of mycobacterial but not viral immunity by a germline human STAT1 mutation
123. Essential role of STAT3 in the control of the acute-phase response as revealed by inducible gene inactivation in the liver
124. Stat3 activation is responsible for 11-6-dependent T cell proliferation through preventing apoptosis: Generation and characterization of T cell-specific Stat3-deficient mice
125. H 1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils
126. STAT3 is a negative regulator of granulopoiesis but is not required for G-CSF-dependent differentiation
127. The virus battles: IFN induction of the antiviral state and mechanisms of viral evasion
128. Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway
129. Selective STAT protein degradation induced by paramyxoviruses requires both STAT1 and STAT2 but is independent of α/β interferon signal transduction
130. The V protein of human parainfluenza virus 2 antagonizes type I interferon responses by destabilizing signal transducer and activator of transcription 2
131. Longer and shorter forms of Sendai virus C proteins play different roles in modulating the cellular antiviral response
132. Hepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response
133. Vesicular stomatitis virus matrix protein inhibits host cell gene expression by targeting the nucleopodn Nup98
134. Inhibition of Ran guanosine triphosphatase-dependent nuclear transport by the matrix protein of vesicular stomatitis virus
135. Role of nucleoporin induction in releasing an mRNA nuclear export block
136. Inhibition of basal transcription by poliovirus: A virus- encoded protease (3Cpro) inhibits formation of TBP-TATA box complex in vitro
137. Oncogenic kinase signalling
138. Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice
139. STAT1 affects lymphocyte survival and proliferation partially independent of its role downstream of IFN-γ
140. Distinct requirements for IFNs and STAT1 in NK cell function
141. IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
142. STAT proteins and cancer
143. Stat3 as an oncogene
144. STATs in oncogenesis
145. STAT signaling in head and neck cancer
146. SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity
147. Multilevel dysregulation of STAT3 activation in anaplastic lymphoma kinase-positive T/null-cell lymphoma
148. Platelet-derived growth factor induces phosphorylation of multiple JAK family kinases and STAT proteins
149. Roles of JAKs in activation of STATs and stimulation of c-fos gene expression by epidermal growth facton
150. ErbB receptor-induced activation of Stat transcription factors is mediated by Src tyrosine kinases
151. Activation of Stat3 preassembled with platelet-derived growth factor β receptors requires Src kinase activity
152. Role of G β-subunit in angiotensin II-type 1 receptor signaling
153. Thrombin regulates vascular smooth muscle cell growth and heat shock proteins via the JAK-STAT pathway
154. Involvement of JAK/STAT (Janus kinase/signal transducer and activator of transcription) in the thyrotropin signaling pathway
155. Enhanced DNA-binding of a Stat3-related protein in cells transformed by the Src oncoprotein
156. Activation and association of Stat3 with Src in v-Src-transformed cell lines
157. Direct stimulation of JAk/STAT pathway by the angiotensin II AT1 receptor
158. Stat2 binding to the interferon-α receptor 2 subunit is not required for interferon-α signaling
159. Complex roles of Stat1 in regulating gene expression
160. Stat1-dependent and -independent pathways in IFN-γ- dependent signaling
161. Crystal structure of a tyrosine phosphorylated STAT-1 dimer bound to DNA